ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Identification of Subgroups of Early Breast Cancer Patients at High Risk of Nonadherence to Adjuvant Hormone Therapy: Results of an Italian Survey
Clinical Breast Cancer
◽
10.1016/j.clbc.2014.10.005
◽
2015
◽
Vol 15
(2)
◽
pp. e131-e137
◽
Cited By ~ 17
Author(s):
Nicola Tinari
◽
Caterina Fanizza
◽
Marilena Romero
◽
Elisabetta Gambale
◽
Luca Moscetti
◽
...
Keyword(s):
Breast Cancer
◽
High Risk
◽
Hormone Therapy
◽
Cancer Patients
◽
Early Breast Cancer
◽
Breast Cancer Patients
◽
Adjuvant Hormone Therapy
◽
Italian Survey
Download Full-text
Related Documents
Cited By
References
Selecting high-risk early breast cancer patients: What to add to the number of metastatic nodes?
European Journal of Cancer
◽
10.1016/0959-8049(95)00442-4
◽
1996
◽
Vol 32
(1)
◽
pp. 41-46
◽
Cited By ~ 8
Author(s):
F. Perrone
◽
C. Carlomagno
◽
R. Lauria
◽
M. De Laurentiis
◽
A. Morabito
◽
...
Keyword(s):
Breast Cancer
◽
High Risk
◽
Cancer Patients
◽
Early Breast Cancer
◽
Breast Cancer Patients
Download Full-text
122MO Quality of life from the Penelope-B study on high-risk HR+/HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib
Annals of Oncology
◽
10.1016/j.annonc.2021.08.403
◽
2021
◽
Vol 32
◽
pp. S410-S411
Author(s):
J.A. García-Saenz
◽
F. Marmé
◽
H.S. Rugo
◽
M. Untch
◽
H. Bonnefoi
◽
...
Keyword(s):
Breast Cancer
◽
Quality Of Life
◽
High Risk
◽
Cancer Patients
◽
Endocrine Therapy
◽
Early Breast Cancer
◽
Breast Cancer Patients
Download Full-text
Adjuvant Olaparib Improves Outcomes in High-Risk, HER2-Negative Early Breast Cancer Patients With Germline BRCA1 and BRCA2 Mutations
10.12788/jcom.0074
◽
2021
◽
Vol 28
(6)
◽
Author(s):
Abdelsamia
Keyword(s):
Breast Cancer
◽
High Risk
◽
Cancer Patients
◽
Early Breast Cancer
◽
Breast Cancer Patients
◽
Brca1 And Brca2
◽
Brca2 Mutations
◽
Brca1 And Brca2 Mutations
Download Full-text
HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumab
The Breast
◽
10.1016/j.breast.2020.10.002
◽
2020
◽
Vol 54
◽
pp. 235-241
◽
Cited By ~ 2
Author(s):
Shuai Li
◽
Jiayi Wu
◽
Ou Huang
◽
Jianrong He
◽
Li Zhu
◽
...
Keyword(s):
Breast Cancer
◽
Estrogen Receptor
◽
High Risk
◽
Cancer Patients
◽
Early Breast Cancer
◽
Breast Cancer Patients
◽
Estrogen Receptor Positive
◽
Her2 Positivity
Download Full-text
Persistence of circulating tumor cells in high risk early breast cancer patients five years after adjuvant chemotherapy and late recurrence: Results from the adjuvant SUCCESS A trial.
Journal of Clinical Oncology
◽
10.1200/jco.2018.36.15_suppl.515
◽
2018
◽
Vol 36
(15_suppl)
◽
pp. 515-515
◽
Cited By ~ 6
Author(s):
Wolfgang Janni
◽
Brigitte Kathrin Rack
◽
Peter A. Fasching
◽
Lothar Haeberle
◽
Hans Tesch
◽
...
Keyword(s):
Breast Cancer
◽
High Risk
◽
Adjuvant Chemotherapy
◽
Cancer Patients
◽
Tumor Cells
◽
Circulating Tumor Cells
◽
Early Breast Cancer
◽
Late Recurrence
◽
Breast Cancer Patients
Download Full-text
HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy
Journal of Translational Medicine
◽
10.1186/1479-5876-10-10
◽
2012
◽
Vol 10
(1)
◽
Cited By ~ 25
Author(s):
George Fountzilas
◽
Christos Valavanis
◽
Vassiliki Kotoula
◽
Anastasia G Eleftheraki
◽
Konstantine T Kalogeras
◽
...
Keyword(s):
Breast Cancer
◽
High Risk
◽
Cancer Patients
◽
Early Breast Cancer
◽
Breast Cancer Patients
◽
Sequential Chemotherapy
◽
Dose Dense
Download Full-text
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial
Breast Cancer Research and Treatment
◽
10.1007/s10549-017-4358-6
◽
2017
◽
Vol 165
(3)
◽
pp. 573-583
◽
Cited By ~ 55
Author(s):
Ulrike Nitz
◽
Oleg Gluz
◽
Matthias Christgen
◽
Ronald E. Kates
◽
Michael Clemens
◽
...
Keyword(s):
Breast Cancer
◽
High Risk
◽
Cancer Patients
◽
Early Breast Cancer
◽
Low Risk
◽
Study Group
◽
Breast Cancer Patients
◽
Phase 3
◽
German Study
Download Full-text
The early discontinuation of adjuvant hormone therapy is associated with a poor prognosis in Japanese breast cancer patients
Surgery Today
◽
10.1007/s00595-013-0762-7
◽
2013
◽
Vol 44
(10)
◽
pp. 1841-1846
◽
Cited By ~ 5
Author(s):
Kenji Taketani
◽
Eriko Tokunaga
◽
Nami Yamashita
◽
Kimihiro Tanaka
◽
Sayuri Akiyoshi
◽
...
Keyword(s):
Breast Cancer
◽
Hormone Therapy
◽
Cancer Patients
◽
Poor Prognosis
◽
Breast Cancer Patients
◽
Early Discontinuation
◽
Adjuvant Hormone Therapy
Download Full-text
135P Hot flashes during adjuvant hormone therapy predict treatment discontinuation and outcome among breast cancer patients
Annals of Oncology
◽
10.1016/j.annonc.2021.08.416
◽
2021
◽
Vol 32
◽
pp. S418
Author(s):
E. Zeng
◽
W. He
◽
K.E. Smedby
◽
K. Czene
Keyword(s):
Breast Cancer
◽
Hormone Therapy
◽
Cancer Patients
◽
Hot Flashes
◽
Treatment Discontinuation
◽
Breast Cancer Patients
◽
Adjuvant Hormone Therapy
Download Full-text
Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial
Breast Cancer Research and Treatment
◽
10.1007/s10549-018-05105-8
◽
2019
◽
Vol 175
(1)
◽
pp. 265-266
◽
Cited By ~ 2
Author(s):
Ulrike Nitz
◽
Oleg Gluz
◽
Matthias Christgen
◽
Ronald E. Kates
◽
Michael Clemens
◽
...
Keyword(s):
Breast Cancer
◽
High Risk
◽
Cancer Patients
◽
Early Breast Cancer
◽
Low Risk
◽
Study Group
◽
Breast Cancer Patients
◽
Phase 3
◽
German Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close